Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascletis Completes Enrollment of Phase III Trial of ASC40 (Denifanstat) Once-Daily Oral Tablet for Treatment of Acne 2024-11-12 19:30
Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks 2024-11-12 19:00
World's First Patent Acquired for Animal Supplement "Pinfenon" (S) (R) 2024-11-12 14:00
Economist Impact's 4th edition Future of Health Asia to empower healthcare stakeholders by building strategies for a sustainable healthcare system, and igniting investment for an inclusive and healthier future 2024-11-11 20:56
Diabetes Singapore and GSK Join Forces to Spotlight Increased Risk of Viral Infections for People with Diabetes 2024-11-11 20:47
ObesityWeek®️ 2024 | Gan & Lee Pharmaceuticals Orally Presents Phase 2b Clinical Data for GZR18 Injection in Chinese Overweight and Obese Adults 2024-11-11 19:36
TB Alliance Joins Indonesia's High-Level Meeting on TB 2024-11-11 10:30
Late-Breaking Abstract! Alphamab Oncology Presented the Latest Clinical Data of Anti-HER2 bispecific ADC Subcutaneous Co-formulation JSKN033 at SITC 2024 2024-11-11 10:04
Henlius and SVAX Forge Strategic Partnership in the MENAT Market 2024-11-09 00:35
Ascletis Announces Promising Results from a Phase I Study in Australia for First-in-Class Muscle-Preserving Weight Loss Drug Candidate ASC47 for the Treatment of Obesity 2024-11-07 19:30
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders 2024-11-07 16:29
Fosun Attends CIIE for the Seventh Time - Guo Guangchang: Confident that China's High-Level Openness is a Historical Opportunity 2024-11-07 13:18
Approx. USD 4.0 M Invested in Product Development for NTDs - GHIT's First Investment in the Development of Diagnostics for Trachoma 2024-11-07 10:00
ASH 2024 | Results From Three Clinical Studies of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax Selected for Presentations, Including an Oral Report 2024-11-06 16:09
ASH 2024 | Studies of Olverembatinib Selected for Presentations, Including an Oral Report, for the Seventh Consecutive Year 2024-11-06 15:56
Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma 2024-11-06 15:20
Antengene Presents Results from Three Investigational Programs at the 2024 SITC Annual Meeting 2024-11-06 09:08
Antengene to Present Results from Two Late-Stage Studies of Selinexor Signaling Potential Clinical Breakthrough at ASH 2024 2024-11-06 08:30
MedAdvisor Solutions Launches Telehealth Service on MedAdvisor Patient App, Further Enhancing Access to Care 2024-11-06 06:47
Embrace Autumn Outdoor Activities: Renowned Traditional Chinese Medicine Expert Professor Tinly Wong Tin-Chee Offers Effective Solutions for Relieving Post-Exercise Muscle Soreness with Massage, Herbal Oils, and Plasters 2024-11-04 09:00
1 2 3 4 5 246